NCT02866838View on ClinicalTrials.gov

Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2021

Study Completion Date

March 22, 2022

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

Tranexamic acid

intravenous

DRUG

Saline 0.9%

intravenous

Trial Locations (1)

4031

Stroke Center, University Hospital Basel, Basel

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02866838 - Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist | Biotech Hunter | Biotech Hunter